Gilead Sciences buys Danish biotech company
A small, Danish-based biotech company has been sold to US drug giant Gilead Sciences for USD 65 million.
BY LONNI LYNGE
The privately-held, Danish-based biotech company EpiTherapeutics has been sold to US-based Gilead Sciences for an all-cash amount of USD 65 million, the biotech company says in a press release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
EpiTherapeutics approaches the clinic
For abonnenter
”There’s more money than there has been in years”
For abonnenter
EpiTherapeutics brings in Merck’s oncology deputy
For abonnenter
